Consultant in Public Health Pharmacy, NHS Tayside, Scotland
Andrew Radley joined the Tayside Pharmacy Management Team in 1994 and was Trust Chief Pharmacist for the Perth and Kinross Healthcare NHS Trust. In 2006, he was appointed as Consultant in Pharmaceutical Public Health for Tayside NHS Board and provides leadership for pharmaceutical public health and allied health topics. His main areas of activity in this role are centred on harnessing the public health role of community pharmacy to improve the health of the population. Andrew participates in the work of the Liver Group at the University Of Dundee and has a number of research interests including the use of incentives as a way of stimulating behaviour change and the use of pharmacy services to address health inequalities. He has undertaken a PhD on treating Hepatitis C in community pharmacy settings.
‘Dot C – Community Pharmacy Hep C treatment’
Elimination of Hepatitis as a public health concern from our communities is one of the tasks set out in the World Health Organisation’s Sustainable Development Goals. In the United Kingdom, the largest part of the burden of Hepatitis C is borne by people who inject drugs. The introduction of new medicines technology means that Direct-Acting Antiviral Drugs can cure this potentially fatal and debilitating disease with 8 weeks of oral therapy. The work undertaken through the University of Dundee demonstrates that community pharmacy can test, diagnose, assess for treatment and cure people with Hepatitis C infection. The evidence generated by this research programme underlines the value of pharmacy as an enabling force in delivering effective patient-centred care to a vulnerable group.